Mark Jit
Titel
Geciteerd door
Geciteerd door
Jaar
Social contacts and mixing patterns relevant to the spread of infectious diseases
J Mossong, N Hens, M Jit, P Beutels, K Auranen, R Mikolajczyk, ...
PLoS Med 5 (3), e74, 2008
14282008
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson
The Lancet infectious diseases 12 (10), 781-789, 2012
3862012
Economic evaluation of human papillomavirus vaccination in the United Kingdom
M Jit, YH Choi, WJ Edmunds
Bmj 337, 2008
3072008
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White, WJ Edmunds
Vaccine 28 (12), 2370-2384, 2010
1852010
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy
The Lancet Global Health 2 (7), e406-e414, 2014
1612014
The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy
D Cromer, AJ van Hoek, M Jit, WJ Edmunds, D Fleming, E Miller
Journal of Infection 68 (4), 363-371, 2014
1392014
Evaluating rotavirus vaccination in England and Wales:: Part II. The potential cost-effectiveness of vaccination
M Jit, WJ Edmunds
Vaccine 25 (20), 3971-3979, 2007
1382007
Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
D Mesher, K Soldan, R Howell-Jones, K Panwar, P Manyenga, M Jit, ...
Vaccine 32 (1), 26-32, 2013
1362013
Estimation of the impact of genital warts on health-related quality of life
S Woodhall, T Ramsey, C Cai, S Crouch, M Jit, Y Birks, WJ Edmunds, ...
Sexually transmitted infections 84 (3), 161-166, 2008
1352008
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
J Bilcke, P Beutels, M Brisson, M Jit
Medical Decision Making 31 (4), 675-692, 2011
1282011
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
M Jit, R Chapman, O Hughes, YH Choi
BMJ 343, d5775, 2011
1232011
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
1202016
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study
S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ...
PLoS medicine 13 (11), e1002181, 2016
1152016
Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
MA Penny, R Verity, CA Bever, C Sauboin, K Galactionova, S Flasche, ...
The Lancet 387 (10016), 367-375, 2016
1132016
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
YH Choi, M Jit, N Gay, A Cox, GP Garnett, WJ Edmunds
Vaccine 28 (24), 4091-4102, 2010
1062010
Modelling the transmission of healthcare associated infections: a systematic review
E van Kleef, JV Robotham, M Jit, SR Deeny, WJ Edmunds
BMC Infectious Diseases 13 (1), 294, 2013
1042013
Evaluating rotavirus vaccination in England and Wales:: Part I. Estimating the burden of disease
JP Harris, M Jit, D Cooper, WJ Edmunds
Vaccine 25 (20), 3962-3970, 2007
1022007
Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review
M Fesenfeld, R Hutubessy, M Jit
Vaccine 31 (37), 3786-3804, 2013
992013
What types of contacts are important for the spread of infections? Using contact survey data to explore European mixing patterns
A Melegaro, M Jit, N Gay, E Zagheni, WJ Edmunds
Epidemics 3 (3), 143-151, 2011
982011
A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls
E Draper, SL Bissett, R Howell-Jones, P Waight, K Soldan, M Jit, ...
PLOS ONE 8 (5), e61825, 2013
972013
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20